Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
FT Vest U.S. Equity Max Buffer ETF - February
FEBM
$46.2M
| $155K | ﹤0.01% |
4,880
| – | – |
2025 Q2
5 quarters
|
|
4052
RCI Hospitality Holdings
RICK
$212M
| $155K | ﹤0.01% |
5,731
+1,864
| +48% | +$52K |
2015 Q3
44 quarters
|
|
4053
Innovator Equity Dual Directional 15 Buffer ETF Dec
DDFD
$99.1M
| $155K | ﹤0.01% |
7,603
-2,284
| -23% | -$46.1K |
2026 Q2
1 quarter
|
|
4054
FT Vest US Equity Deep Buffer ETF February
DFEB
$458M
| $154K | ﹤0.01% |
2,988
| – | – |
2024 Q3
8 quarters
|
|
4055
Similarweb
SMWB
$711M
| $154K | ﹤0.01% |
19,866
+19,176
| +2,779% | +$149K |
2023 Q2
13 quarters
|
|
4056
Chaince Digital Holdings
CD
$573M
| $154K | ﹤0.01% |
25,632
+15,938
| +164% | +$56.3K |
2025 Q2
5 quarters
|
|
4057
Gladstone Land Corp
LAND
$317M
| $154K | ﹤0.01% |
16,267
-23,983
| -60% | -$213K |
2017 Q4
35 quarters
|
|
4058
Intercorp Financial Services
IFS
$5.62B
| $154K | ﹤0.01% |
2,826
+2,366
| +514% | +$134K |
2025 Q2
5 quarters
|
|
4059
Aya Gold & Silver Inc
AYA
$3.52B
| $153K | ﹤0.01% |
5,700
-55,761
| -91% | -$1.38M |
2026 Q2
1 quarter
|
|
4060
One Liberty Properties
OLP
$466M
| $153K | ﹤0.01% |
6,974
+4,422
| +173% | +$106K |
2013 Q2
53 quarters
|
|
4061
State Street SPDR S&P Global Dividend ETF
WDIV
$282M
| $153K | ﹤0.01% |
1,880
| – | – |
2026 Q1
2 quarters
|
|
4062
Norwood Financial Corp
NWFL
$396M
| $153K | ﹤0.01% |
4,624
+2,556
| +124% | +$85.5K |
2022 Q3
16 quarters
|
|
4063
FT Vest US Equity Buffer ETF December
FDEC
$1.34B
| $152K | ﹤0.01% |
2,721
| – | – |
2026 Q2
1 quarter
|
|
4064
Magnera Corp
MAGN
$470M
| $152K | ﹤0.01% |
13,435
+7,989
| +147% | +$100K |
2022 Q1
18 quarters
|
|
4065
Acco Brands
ACCO
$492M
| $152K | ﹤0.01% |
36,182
+21,234
| +142% | +$89.4K |
2013 Q2
53 quarters
|
|
4066
DiaMedica Therapeutics
DMAC
$527M
| $152K | ﹤0.01% |
18,353
+5,208
| +40% | +$36.4K |
2024 Q4
7 quarters
|
|
4067
Citizens Financial Services
CZFS
$415M
| $151K | ﹤0.01% |
1,919
-812
| -30% | -$63.8K |
2023 Q1
14 quarters
|
|
4068
Monopar Therapeutics
MNPR
$482M
| $151K | ﹤0.01% |
1,893
-3,940
| -68% | -$423K |
2025 Q1
6 quarters
|
|
4069
Invesco Solar ETF
TAN
$962M
| $151K | ﹤0.01% |
3,426
-18,733
| -85% | -$938K |
2020 Q3
24 quarters
|
|
4070
Quanterix
QTRX
$147M
| $150K | ﹤0.01% |
40,562
+24,757
| +157% | +$81.5K |
2018 Q1
34 quarters
|
|
4071
American Vanguard Corp
AVD
$26.3M
| $150K | ﹤0.01% |
85,895
-2,300
| -3% | -$5.42K |
2013 Q2
53 quarters
|
|
4072
PUT
Ultragenyx Pharmaceutical
RARE
$1.69B
| $150K | ﹤0.01% |
+10,000
| New | +$240K |
2026 Q3
0 quarters
|
|
4073
FVCBankcorp
FVCB
$293M
| $150K | ﹤0.01% |
8,617
+4,084
| +90% | +$74.2K |
2022 Q2
17 quarters
|
|
4074
Relmada Therapeutics
RLMD
$476M
| $150K | ﹤0.01% |
39,798
-11,436
| -22% | -$56.1K |
2025 Q2
5 quarters
|
|
4075
Innovator Equity Defined Protection ETF - 2 Yr to January 2027
TJAN
$32.4M
| $150K | ﹤0.01% |
5,229
| – | – |
2025 Q3
4 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.